2567-51-3

Basic information

• Product Name: N,N-Dibenzyl-2-chloro-acetamide
• Synonyms: N,N-Dibenzyl-2-chloro-acetamide
• CAS NO: 2567-51-3
• Molecular Formula: C₁₆H₁₆ClNO
• Molecular Weight: 273.76
• Mol File: 2567-51-3.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 432.1 °C at 760 mmHg
• Flash Point: 215.1 °C
• Appearance: /
• Density: 1.181 g/cm³
• Vapor Pressure: 1.14E-07mmHg at 25°C
• Refractive Index: 1.589
• CAS DataBase Reference: N,N-Dibenzyl-2-chloro-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-Dibenzyl-2-chloro-acetamide(2567-51-3)
• EPA Substance Registry System: N,N-Dibenzyl-2-chloro-acetamide(2567-51-3)

Safety Data

• Hazardous Substances Data: 2567-51-3(Hazardous Substances Data)

Usage

Uses

N,N-Dibenzyl-2-chloroacetamide (cas# 2567-51-3) is a useful reactant for the diastereo-/chemoselective preparation of vinyl silanes/silyl-substituted alpha, beta-unsaturated amides by Pd-catalyzed olefination.

InChI:InChI=1/C16H16ClNO/c17-11-16(19)18(12-14-7-3-1-4-8-14)13-15-9-5-2-6-10-15/h1-10H,11-13H2

Upstream product

• 79-04-9 chloroacetyl chloride 
• 103-49-1 dibenzylamine 
• 22118-09-8 2-bromoacetyl chloride 
• 4015-58-1 monochloroacetic acid anhydride 

Downstream Products

• 752994-27-7 2,2'-[5,6-(1,10-phenanthroline)bis(oxy)]-bis(N,N-dibenzylacetamide) 
• 51-50-3 N,N-dibenzyl-2-chloroethanamine 
• 6772-73-2 1,4-dihydro-2-(phenylmethyl)-3(2H)-isoquinolinone 
• 437618-41-2 2-(dibenzylamino)-2-oxoethyl adamantane-1-carboxylate 
• 19340-71-7 (R)-1-benzyl-4-phenylazetidin-2-one 
• 1428962-44-0 N,N-dibenzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide hydrochloride 
• 1428962-06-4 N,N-dibenzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide 
• 617695-07-5 N,N-dibenzyl-3-methylbenzofuran-2-carboxamide 
• 1093977-02-6 N,N-dibenzyl-2-{4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}acetamide 
• 1093981-57-7 2-azido-N,N-dibenzylacetamide 
• 252667-35-9 (E)-4,4-dimethyl-N,N-bis(phenylmethyl)-2-pentenamide 
• 55334-41-3 3-phenyl-N,N-bis(phenylmethyl)-2-propenamide 

Relevant articles and documents

Tauroursodeoxycholic acid derivative, and pharmaceutical composition and preparation containing same

The invention provides a tauroursodeoxycholic acid derivative, a pharmaceutical composition and a preparation containing the tauroursodeoxycholic acid derivative and pharmaceutical application. The tauroursodeoxycholic acid derivative has a structure repr

Latent Bronsted Base Solvent-Assisted Amide Formation from Amines and Acid Chlorides

Weakly basic amines, including even neutral amines such as nitroaniline and aminocarboxylic acids, react with acid chlorides very efficiently in N, N -dimethylacetamide (DMAC), without addition of a base, to give the corresponding amides in high yields. The role of DMAC and related solvents as latent Bronsted bases was studied in these amidation reactions. Less basic amines, such as aromatic amines, reacted with benzoyl chloride faster than more basic aliphatic amines.

Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents

A series of novel 1-methyl-3-substituted quinazoline-2,4-dione derivatives were designed, synthesized, and characterized by 1H NMR, 13C NMR and MS spectral data. Their inhibition against chitin synthase (CHS) and antifungal activities were evaluated in vitro. Results showed compounds 5b, 5c, 5e, 5f, 5j, 5k, 5l, and 5o had strong inhibitory potency against CHS. Compound 5c, which has the highest potency among these compounds, had a half-inhibition concentration (IC50) of 0.08 mmol/L, while polyoxin B as positive drug had IC50 of 0.18 mmol/L. These IC 50 values of compounds 5i, 5m, 5n, and 5s were greater than 0.75 mmol/L, which revealed that those compounds had weak inhibition activity against CHS. Moreover, most of these compounds exhibited moderate to excellent antifungal activities. In detail, to Candida albicans, the activities of compound 5g and 5k were 8-fold stronger than that of fluconazole and 4-fold stronger than that of polyoxin B; to Aspergillus flavus, the activities of 5g, 5l and 5o were16-fold stronger than that of fluconazole and 8-fold stronger than that of polyoxin B; to Cryptococcus neoformans, the minimum-inhibition- concentration (MIC) values of compounds 5c, 5d, 5e and 5l were comparable to those of fluconazole and polyoxin B. The antifungal activities of these compounds were positively correlated to their IC50 values against CHS. Furthermore, these compounds had negligible actions to bacteria. Therefore, these compounds were promising selective antifungal agents.